Status:

COMPLETED

Effect of Sham Anti-inflammatory Diet on Inflammation After Spinal Cord Injury

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborating Sponsors:

Ontario Neurotrauma Foundation

Conditions:

Spinal Cord Injury

Inflammation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This pilot study will evaluate the effects of a placebo anti-inflammatory diet in individuals with spinal cord injury. It is being performed to ensure that the placebo diet does not induce reductions ...

Detailed Description

Anti-inflammatory diet is a novel treatment that may be beneficial for managing chronic inflammation and neuropathic pain (NP) after Spinal Cord Injury (SCI). NP is a common complication following SCI...

Eligibility Criteria

Inclusion

  • Signed informed consent obtained prior to any study-related activities
  • A spinal cord injury at least 6 months duration, nonprogressive for at least 6 months
  • Dosing of other pain medications (NSAIDs, opioids, non-opioid analgesics, anti-epileptic drugs, antidepressants) should be stable for at least 1 month prior to study entry.

Exclusion

  • Current infection of any kind.
  • Presence of other neurologic conditions, medical conditions or pain that could confound the assessment of neuropathic pain after SCI
  • Currently enrolled in another clinical trial
  • Any other significant disease or disorder which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, may influence the result of the study, or affect the patient's ability to participate in the study
  • Following a physical examination, the patient has any abnormalities that, in the opinion of the investigator would prevent the patient from safe participation in the study

Key Trial Info

Start Date :

October 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 3 2022

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04271904

Start Date

October 1 2020

End Date

June 3 2022

Last Update

January 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Parkwood Institute

London, Ontario, Canada, N6C 5J1